Ground Truths-We’ll discuss any biomedical topics of interest!

Join me for a live zoom conversation on Wednesday, January 29 at 10 AM PST

Medicial Breakthroughs January 25,2025 0

Ground Truths-We’ll discuss any biomedical topics of interest!

Join me for a live zoom conversation on Wednesday, January 29 at 10 AM PST

Medicial Breakthroughs January 25,2025 0

Pop a Sleeping Pill, and Your Brain Ends Up with Extra “Trash”

In a recent study published in Cell, researchers investigated how the brain cleans itself during natural sleep—and found that zolpidem seems to interfere with this process.

Sleep January 25,2025 0

Pop a Sleeping Pill, and Your Brain Ends Up with Extra “Trash”

In a recent study published in Cell, researchers investigated how the brain cleans itself during natural sleep—and found that zolpidem seems to interfere with this process.

Sleep January 25,2025 0

About Antiviral Drugs – Baloxavir

Public Health&Prevention January 25,2025 0

About Antiviral Drugs – Baloxavir

Public Health&Prevention January 25,2025 0

Dr. Yale Gong and His USMLE Book

Education January 24,2025 0

Dr. Yale Gong and His USMLE Book

Education January 24,2025 0

Weekly Update of Drug News-22/1/2025

Drug Discovery January 23,2025 0

Weekly Update of Drug News-22/1/2025

Drug Discovery January 23,2025 0

New microscopy technique could enable rapid tumor analysis in the operating room

byCalifornia Institute of TechnologyThese images show the high resolution achieved with the new microscopy technique. A mouse brain cross-section as seen with photoacoustic imaging is shown in t

Hematology&Oncology January 22,2025 0

New microscopy technique could enable rapid tumor analysis in the operating room

byCalifornia Institute of TechnologyThese images show the high resolution achieved with the new microscopy technique. A mouse brain cross-section as seen with photoacoustic imaging is shown in t

Hematology&Oncology January 22,2025 0

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Hematology&Oncology January 22,2025 0

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Hematology&Oncology January 22,2025 0

Treating advanced prostate cancer

by Nicole Ferrara,Mayo ClinicCredit: Pixabay/CC0 Public DomainAdvanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or

Hematology&Oncology January 22,2025 0

Treating advanced prostate cancer

by Nicole Ferrara,Mayo ClinicCredit: Pixabay/CC0 Public DomainAdvanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or

Hematology&Oncology January 22,2025 0

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Hematology&Oncology January 22,2025 0

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Hematology&Oncology January 22,2025 0

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Hematology&Oncology January 22,2025 0

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Hematology&Oncology January 22,2025 0